Life

Health, science, climate, and society-focused reporting.

Impact of Delayed Medical Appointments on Patient Behavior

Patients facing delays in accessing healthcare services are increasingly turning to alternative sources for medical advice, raising concerns about misinformation.

Editorial Staff Apr 2

Life

Cardiology Shifts Focus to Prevention in National Conferences

The emphasis on prevention in cardiology is gaining traction, moving from the margins to a central theme at national medical conferences.

Editorial Staff Apr 2

Life

Evaluating Deepfake Detection in Radiology: A STAT Report

A recent STAT report examines the challenges of identifying deepfake X-rays, as a reporter tests radiologists' capabilities in this emerging issue.

Editorial Staff Apr 2

Life

Impending 100% Tariffs on Imported Drugs: Infrastructure Implications

The Trump administration is preparing to implement a 100% tariff on certain imported medications, as indicated by a draft order. This move could significantly impact supply chains and pricing structures.

Editorial Staff Apr 2

Life

FDA Commissioner Reflects on First Year: Achievements and Infrastructure

In a recent address, FDA Commissioner Makary highlighted key accomplishments over the past year, emphasizing staff contributions and operational improvements.

Editorial Staff Apr 1

Life

AI Scribes Demonstrate Limited Efficiency Gains in Healthcare Settings

A recent study across five academic medical centers indicates that AI scribes can save doctors about 16 minutes during an eight-hour shift, though usage remains inconsistent.

Editorial Staff Apr 1

Life

FDA's Advisory Committee Conflict of Interest Guidance Needs Urgent Finalization

A recent review highlights the FDA's inconsistent disclosure of financial conflicts of interest among advisory committee members, emphasizing the need for new guidance.

Editorial Staff Apr 1

Life

Eli Lilly’s Obesity Pill Gains FDA Approval, Competing with Novo Nordisk’s Wegovy

Eli Lilly has received FDA approval for its obesity pill, which will directly compete with Novo Nordisk's Wegovy. This development has significant implications for market dynamics in obesity treatment.

Editorial Staff Apr 1

Life

State-Specific Exceptions to Abortion Bans and Gestational Limits Documented

A comprehensive policy tracker outlines exceptions to the most restrictive abortion laws across states, detailing gestational limits and total bans.

Editorial Staff Apr 1

Life

Insilico Medicine's AI Integration Strategies in Drug Development

Alex Zhavoronkov, CEO of Insilico Medicine, outlines essential practices for effectively incorporating AI into drug development processes.

Editorial Staff Apr 1

Life

Novo's Subscription Model and Its Implications for Pharma-Telehealth Collaborations

Novo's recent subscription model raises critical questions regarding the integration of pharmaceutical companies with telehealth services, particularly in light of regulatory delays.

Editorial Staff Apr 1

Life

FDA Reconsiders Injectable Peptide Compounding Regulations

The FDA's potential shift on injectable peptide compounding could reshape industry practices, previously hindered by safety concerns. The ongoing conflict in Iran is also affecting trial recruitment.

Editorial Staff Apr 1

Life

Public Concerns Over Immigration Enforcement in Health Care Settings

Recent polling indicates significant public disapproval of ICE operations in hospitals, particularly following policy changes regarding sensitive locations.

Editorial Staff Apr 1

Life

Exploring the Integration of Psychotherapy in Ketamine Treatment

A recent study investigates the potential benefits of combining psychotherapy with ketamine therapy, aiming to enhance treatment outcomes for patients.

Editorial Staff Apr 1

Life

Controversy Arises Over NIH Director's Reference to Vannevar Bush in Context of Trump Policies

Jay Bhattacharya's assertion connecting Trump administration policies to Vannevar Bush's vision has led to significant backlash, raising questions about the implications for science policy.

Editorial Staff Apr 1

Life

Evaluating the Use of Medical Marijuana for Mental Health Conditions

The evidence supporting the medical efficacy of marijuana for conditions like PTSD, anxiety, and depression remains limited, raising concerns about its recommendation.

Editorial Staff Apr 1

Life

Medicare's Care Restrictions: Implications for Infrastructure and Patient Capacity

Medicare's recent decision to restrict care for 1 million Americans raises significant concerns about the underlying assumptions and potential impacts on healthcare infrastructure.

Editorial Staff Apr 1

Life

Biotech Scorecard for Q2: Key Stock-Moving Events Identified

STAT has released its biotech scorecard for the second quarter, detailing 23 significant events that could impact stock movements in the sector.

Editorial Staff Apr 1

Life

Potential Renaming of PCOS Reflects New Understanding of Male Hormonal Conditions

The movement to rename Polycystic Ovary Syndrome (PCOS) is gaining traction as research suggests the existence of a male counterpart, indicating a need for more inclusive terminology.

Editorial Staff Apr 1

Life

HSA Industry Advocates for Expanded Access Through New Lobbying Group

A new lobbying group is advocating for broader availability of health savings accounts (HSAs), aiming to reshape the current landscape of health financing.

Editorial Staff Mar 31